Home » Our Team » David Burgess

David Burgess

Senior Regulatory Affairs Associate

David Burgess is a Senior Regulatory Affairs Associate with 25+ years of experience in conducting and managing clinical research. He provides regulatory support for pediatric HIV studies and U.S. Department of Defense clinical trials.

Earlier in his career, Mr. Burgess served on a Human Subjects Protection Team, where he conducted regulatory reviews of domestic and international informed consent documents for the Division of AIDS, National Institute of Allergy and Infectious Diseases. He also worked as a research program coordinator for the Department of Neurology at Johns Hopkins University School of Medicine, where he contributed to the AIDS Clinical Trials Group (ACTG) A5090 Study, the Oxidative Stress Study, the North East AIDS Dementia Study, and the Magnetic Resonance Spectroscopy Study.

David Burgess is a Senior Regulatory Affairs Associate with 25+ years of experience in conducting and managing clinical research. He provides regulatory support for pediatric HIV studies and U.S. Department of Defense clinical trials.

Earlier in his career, Mr. Burgess served on a Human Subjects Protection Team, where he conducted regulatory reviews of domestic and international informed consent documents for the Division of AIDS, National Institute of Allergy and Infectious Diseases. He also worked as a research program coordinator for the Department of Neurology at Johns Hopkins University School of Medicine, where he contributed to the AIDS Clinical Trials Group (ACTG) A5090 Study, the Oxidative Stress Study, the North East AIDS Dementia Study, and the Magnetic Resonance Spectroscopy Study.

Selected Publications and Presentations

1.) Cancelas, J.A., Nestheide, S., Rugg, N., Eckerman, A., Macdonald, V.W., Charles, M.L., Markstrom, L., Atkinson, A.J., King, M.R., Snyder, M., Burgess, D., Murto, J., Valiyaveettil, M.K., Pehta, J.C., and Penegor, S.A. (2021). Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma. Transfusion. doi: 10.1111/trf.16756 PMID: 34951486

Education

MA, English, University of Kentucky

BA, English, Western Maryland College